Company intelligence / Profile preview

Aseptconn

Dietikon, Zurich, Switzerlandaseptconn.ch ↗

Ownership: Private
Development stage: Commercial

Overview

Aseptconn provides critical components and digital solutions to optimize sterile liquid handling in pharmaceutical and biopharmaceutical manufacturing. Their offerings include both proprietary products/services and those from leading suppliers. They are recognized as an innovation partner by many international pharma companies. No clinical results as they do not develop drugs.

Industry: Non-Drug Biotech

Partnerships

Collaborates with leading solution suppliers in the pharmaceutical industry to offer comprehensive product portfolios to clients.

Beyond the preview

Go deeper on Aseptconn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aseptconn.

Explore the full profile